{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-132367","form_type":"8-K","ticker":"ESPR","cik":"0001434868","company_name":"Esperion Therapeutics, Inc.","filed_at":"2021-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.576867+00:00","generated_at":"2026-06-28T15:41:08.783495+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Esperion appoints Seth H.Z. Fischer to its Board of Directors, effective Oct 28, 2021","bullets":["Seth H.Z. Fischer elected as Class III director for term expiring at 2022 annual meeting.","Fischer brings 35+ years pharma/device experience; former CEO of Vivus, group chairman at Johnson & Johnson.","Will serve as chair of Nominating and Governance Committee and member of Compliance Committee.","Board determined Fischer is an independent director under SEC and Nasdaq rules.","Fischer receives standard non-employee director compensation; indemnification agreement executed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-132367","json":"https://secwatch.observer/filing/0001104659-21-132367.json","markdown":"https://secwatch.observer/filing/0001104659-21-132367.md","text":"https://secwatch.observer/filing/0001104659-21-132367.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434868/000110465921132367/0001104659-21-132367-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434868/000110465921132367/tm2130916d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T15:41:08.783495+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e0354abc15","claim":"Seth H.Z. Fischer was elected as Director at Esperion Therapeutics, Inc..","evidence_excerpt":"On October 28, 2021, the Board of Directors (the “Board”) of Esperion Therapeutics, Inc (the “Company”) elected Seth H.Z. Fischer to fill in the newly created vacancy on the Board resulting from an increase in size of the Board from eight (8) directors to nine (9) directors, effective October 28, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1434868/000110465921132367/0001104659-21-132367-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}